Hester Biosciences Limited (HESTERBIO.BO)
- Previous Close
1,660.70 - Open
1,663.75 - Bid --
- Ask --
- Day's Range
1,655.70 - 1,694.85 - 52 Week Range
1,292.90 - 1,928.45 - Volume
480 - Avg. Volume
959 - Market Cap (intraday)
14.323B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
74.93 - EPS (TTM)
22.47 - Earnings Date May 15, 2024 - May 20, 2024
- Forward Dividend & Yield 8.00 (0.47%)
- Ex-Dividend Date Sep 13, 2023
- 1y Target Est
1,620.00
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare, and Others segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, fowl typhoid, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian coccidiosis, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucellosis, contagious bovine pleuropneumonia, and lumpy skin diseases. In addition, the company provides animal health products, such as biosecurity and therapeutic solutions, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticide solutions, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides enzyme-linked immunosorbent assay and polymerase chain reaction diagnostic kits. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.
www.hester.in693
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: HESTERBIO.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HESTERBIO.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HESTERBIO.BO
Valuation Measures
Market Cap
14.37B
Enterprise Value
16.79B
Trailing P/E
75.37
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.91
Price/Book (mrq)
5.10
Enterprise Value/Revenue
5.74
Enterprise Value/EBITDA
28.29
Financial Highlights
Profitability and Income Statement
Profit Margin
6.17%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
2.99B
Net Income Avi to Common (ttm)
184.7M
Diluted EPS (ttm)
22.47
Balance Sheet and Cash Flow
Total Cash (mrq)
144.52M
Total Debt/Equity (mrq)
93.76%
Levered Free Cash Flow (ttm)
--
Research Analysis: HESTERBIO.BO
Company Insights: HESTERBIO.BO
HESTERBIO.BO does not have Company Insights